Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.
Researchers explored the viability and safety of LC16m8, an attenuated vaccinia virus vaccine, to prevent monkeypox. The study evaluated the immunogenicity and safety of LC16m8 across three animal species.
Read storyThree people have been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for their work on the first HIV drug to offer long-lasting protection from infection — eliminating the need for people to take a daily pill.
Scientists have developed an ’Intelligent Autonomous Wiping and UV-C Disinfection Robot’ capable of automating hospital disinfection processes. The system can perform disinfection with consistent precision, significantly reducing the risk of infection within the hospital.
Bird flu (H5N1) is rapidly evolving into the possibility of a human pandemic, say researchers who have been documenting research on bird flu in cats and calling for urgent surveillance of cats to help avoid human-to-human transmission.
Staphylococcus borealis has been found to be resistant to several different types of antibiotics, posing a potentially significant problem for the elderly.
A new study reveals how foot traffic data from mobile devices can enhance neighborhood-level COVID-19 forecasts in New York City, providing a novel approach to predicting the spread of the SARS-CoV-2 virus and improving targeted public health interventions.
Researchers have received more than $4 million from federal and non-governmental organizations to support research on Chagas disease prevalence, diagnostics and treatment to benefit both dogs and humans.
Scientists have characterized a new model of influenza A infection: binding to MHC class II complexes as an alternative receptor and the associated dynamic reorganization of the cell surface.
The Society for Healthcare Epidemiology of America has called for the reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), warning that decades of progress in preventing healthcare-associated infections are under threat.
The Trump adminstration has signed an Executive Order halting federal gain of function research on microbes - but does it throw the baby out with the bathwater? Virologist Simon Wain-Hobson, Emeritus Professor with the Pasteur Institute, Paris, gives his take.
A study by AMI member Dr Gerry Quinn highlights the potential of spiritual healing sites as fertile ground for novel antibiotics, particularly from Streptomyces bacteria, known for producing the majority of current antibiotics.
A new study has uncovered the secrets of a particular strain of the bacterium Klebsiella pneumoniae, revealing a potentially deadly genetic capacity for both antimicrobial resistance and virulence.
The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years before the disease first emerged in humans up to 2,700 kilometers away in Central China, suggesting the wildlife trade played a role.
Scientists have developed AI technology that can detect patterns in gut bacteria to identify complex regional pain syndrome (CRPS) with remarkable accuracy, potentially transforming how CRPS is diagnosed and treated.
Silver nanoparticles produced by the fungus Trichoderma reesei could become important allies in the prevention and treatment of COVID-19. Tests on hamsters showed that they not only inhibited the infection but also reduced the viral load in the lungs.
New research shows how mice fed a Western-style diet are not able to rebuild a ‘healthy’, diverse gut microbiome following antibiotic treatment. These mice were also more susceptible to infection by pathogens like Salmonella.
Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection, potentially placing them at elevated risk for future cardiac and pulmonary conditions.
Biophysicists have figured out how bacteria form robust patterns despite changing environmental conditions and fluctuating protein concentrations.
Health experts say the updated CDC HIV Non-Occupational Post Exposure Prophylaxis (nPEP) Guidelines should be part of general medical practice, as incorporating them will reduce new HIV infections and improve public health.
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid.
Analysis of the gut microbiota of more than 700 babies also showed that breastfeeding was a protective factor, mitigating the problem in those who consumed industrialized products. The study underscores the importance of breastfeeding.
Urban rats spread deadly bacteria as they migrate within cities that can be the source of a potentially life-threatening disease in humans, according to a six-year study that also discovered a novel technique for testing rat kidneys.
Scientists have introduced a promising drug candidate engineered to target a deadly and emerging infection. They took a hyper-detailed look into the problem of Mycobacterium abscessus, and chemically re-engineered a widely-used rifamycin antibiotic.